BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17360589)

  • 1. Accumulation of prion protein in the brain that is not associated with transmissible disease.
    Piccardo P; Manson JC; King D; Ghetti B; Barron RM
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4712-7. PubMed ID: 17360589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.
    Jeffrey M; McGovern G; Chambers EV; King D; González L; Manson JC; Ghetti B; Piccardo P; Barron RM
    Brain Pathol; 2012 Jan; 22(1):58-66. PubMed ID: 21645162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
    Piccardo P; King D; Telling G; Manson JC; Barron RM
    J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious prions and proteinopathies.
    Barron RM
    Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
    Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B
    Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy.
    Baker HF; Ridley RM; Wells GA; Ironside JW
    Neuropathol Appl Neurobiol; 1998 Dec; 24(6):476-86. PubMed ID: 9888158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous generation of infectious prion disease in transgenic mice.
    Torres JM; Castilla J; Pintado B; Gutiérrez-Adan A; Andréoletti O; Aguilar-Calvo P; Arroba AI; Parra-Arrondo B; Ferrer I; Manzanares J; Espinosa JC
    Emerg Infect Dis; 2013 Dec; 19(12):1938-47. PubMed ID: 24274622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of chimaeric murine/ovine PrP (A136H154Q171) in transgenic mice facilitates transmission and differentiation of ruminant prions.
    Griffiths PC; Plater JM; Chave A; Jayasena D; Tout AC; Rice PB; Vickery CM; Spiropoulos J; Stack MJ; Windl O
    J Gen Virol; 2013 Nov; 94(Pt 11):2577-2586. PubMed ID: 23761404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
    Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
    Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.